Cleared Traditional

K823841 - PHADEBAS RAST ALLERGEN DISCS

K823841 is the FDA 510(k) clearance for PHADEBAS RAST ALLERGEN DISCS by Pharmacia, Inc.. It is a Class 2 Immunology device (product code DGC) cleared through the Traditional 510(k) pathway after a 22-day FDA review.

K823841 · Pharmacia, Inc. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1983
Decision
22d
Days
Class 2
Risk

K823841 is an FDA 510(k) clearance for the PHADEBAS RAST ALLERGEN DISCS. Classified as Ige, Antigen, Antiserum, Control (product code DGC), Class II - Special Controls.

Submitted by Pharmacia, Inc. (Walker, US). The FDA issued a Cleared decision on January 12, 1983 after a review of 22 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5510 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Pharmacia, Inc. devices

Submission Details

510(k) Number K823841 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 21, 1982
Decision Date January 12, 1983
Days to Decision 22 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
82d faster than avg
Panel avg: 104d · This submission: 22d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DGC Ige, Antigen, Antiserum, Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5510
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - DGC Ige, Antigen, Antiserum, Control

All 81
Devices cleared under the same product code (DGC) and FDA review panel - the closest regulatory comparables to K823841.
VENTRE/ZYME IGE KIT
K831485 · Ventrex Laboratories, Inc. · Jun 1983
IGE-QUANT DIAGNOSTIC TEST KIT
K831208 · Leeco Diagnostics, Inc. · May 1983
NEW ALLERGEN DISCS FOR USE IN VAST VENT
K830817 · Ventrex Laboratories, Inc. · Apr 1983
PHADEZYM RAST ALLERGEN DISCS
K823842 · Pharmacia, Inc. · Jan 1983
TANDEM-E -IGE IMMUNOEZYMETRIC ASSAY
K823507 · Hybritech, Inc. · Dec 1982
ALLERCOAT POSITIVE CONTROL SERUM
K823403 · Kallestad Laboratories, Inc. · Dec 1982